Thrombosis: all 1,528 studies
Page 16 of 16. Open to participants first (240), then studies with results posted, then the rest; newest registration first within each.
- Alfimeprase for Thrombolysis in Acute Peripheral Arterial OcclusionCompletedNCT00073554Phase 2
- Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access DevicesCompletedNCT00073515Phase 2
- The Role of Susceptibility to Thrombosis in the Pseudotumor Cerebri of Nephropathic Cystinosis: A Case-Control StudyCompletedNCT00071903
- SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein ThrombosisCompletedNCT00071279Phase 3
- Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)CompletedNCT00067093Phase 3
- Transcranial Doppler (TCD) Ultrasound of Subjects Enrolled in BABY HUG - Ancillary to BABY HUGCompletedNCT00059293
- Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck VeinsCompletedNCT00055159Phase 1
- Inflammation Genomics and Atherosclerosis - Ancillary to CARDIACompletedNCT00046605
- Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning)CompletedNCT00043940Phase 3
- Study Of Angiomax In Infants Under Six Months With ThrombosisCompletedNCT00043277Phase 2
- Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer PatientsTerminatedNCT00041782Phase 2
- Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2DCompletedNCT00041405
- Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to HeparinCompletedNCT00039858Phase 4
- Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access DevicesCompletedNCT00039767Phase 2
- Risk Factors for Venous ThromboembolismCompletedNCT00018772
- Genetic Architecture of Plasma T-PA and PAI-1CompletedNCT00007410
- Inflammation Markers Over Time in Cardiovascular DiseaseCompletedNCT00005692
- Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in ThrombosisCompletedNCT00005684
- Lupus Cohort--Thrombotic Events and Coronary Artery DiseaseCompletedNCT00005436
- Thrombogenic Factors and Recurrent Coronary EventsCompletedNCT00005358
- Novel Hemostatic Cardiac Risk Factors in FraminghamCompletedNCT00005356
- Mechanisms Underlying Psychosocial Associations With Ischemic Heart Disease (Kuopio)CompletedNCT00005260
- The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3AStatus unknownNCT00004564Not applicable
- A Randomized Evaluation of the Effect of Routine Normal Saline Flush Versus Heparinized Saline Solution in Groshong and Groshong PICC CathetersCompletedNCT00001518
- Stroke Prevention in Sickle Cell Anemia (STOP 1)CompletedNCT00000592Phase 3
- Dietary Effects on Lipoproteins and Thrombogenic ActivityCompletedNCT00000538Phase 3
- Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)CompletedNCT00000517Phase 3
- Postmenopausal Estrogen/Progestin Interventions (PEPI)CompletedNCT00000466Phase 3